Identifying patient-related predictors of permanent growth hormone deficiency

ObjectiveIsolated childhood growth hormone deficiency (GHD) can persist into adulthood, and re-testing at the transition period is needed to determine whether continued growth hormone therapy is indicated. Here, our objective was to identify predictors of permanent GHD.DesignRetrospective single-cen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in endocrinology (Lausanne) 2023-10, Vol.14, p.1270845-1270845
Hauptverfasser: Mericq, Veronica, Iñiguez, German, Pinto, Graziella, Gonzalez-Briceño, Laura G., Samara-Boustani, Dinane, Thalassinos, Caroline, Flechtner, Isabelle, Stoupa, Athanasia, Beltrand, Jacques, Besançon, Alix, Brabant, Séverine, Ghazal, Khaldoun, Leban, Monique, Touraine, Philippe, Cavada, Gabriel, Polak, Michel, Kariyawasam, Dulanjalee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectiveIsolated childhood growth hormone deficiency (GHD) can persist into adulthood, and re-testing at the transition period is needed to determine whether continued growth hormone therapy is indicated. Here, our objective was to identify predictors of permanent GHD.DesignRetrospective single-centre study of patients with childhood-onset GHD who were re-tested after adult height attainment.MethodsAuxological, clinical, laboratory, and MRI data throughout follow-up were collected.ResultsWe included 101 patients. At GH treatment initiation, age was 8.1 ± 0.4 years, height -2.25 ± 0.8, and BMI -0.27 ± 0.1 SDS. The 29 (28.7%) patients with persistent GHD had lower height SDS (-2.57 ± 0.1 vs. -2.11 ± 0.1, p
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2023.1270845